Bobath therapy, or neurodevelopmental therapy (NDT) is widely practiced despite evidence other interventions are more effective in cerebral palsy (CP). The objective is to determine the efficacy of NDT in children and infants with CP or high risk of CP.
Cumulative Index to Nursing and Allied Health Literature, Cochrane Library, Embase, and Medline were searched through March 2021. Randomized controlled trials comparing NDT with any or no intervention were included. Meta-analysis was conducted with standardized mean differences calculated. Quality was assessed by using Cochrane Risk of Bias tool-2 and certainty by using Grading of Recommendations Assessment, Development, and Evaluation.
Of 667 records screened, 34 studies (in 35 publications, 1332 participants) met inclusion. Four meta-analyses were conducted assessing motor function. We found no effect between NDT and control (pooled effect size 0.13 [−0.20 to 0.46]), a moderate effect favoring activity-based approaches (0.76 [0.12 to 1.40]) and body function and structures (0.77 [0.19 to 1.35]) over NDT and no effect between higher- and lower-dose NDT (0.32 [−0.11 to 0.75]). A strong recommendation against the use of NDT at any dose was made. Studies were not all Consolidated Standards of Reporting Trials-compliant. NDT versus activity-based comparator had considerable heterogeneity (I2 = 80%) reflecting varied measures.
We found that activity-based and body structure and function interventions are more effective than NDT for improving motor function, NDT is no more effective than control, and higher-dose NDT is not more effective than lower-dose. Deimplementation of NDT in CP is required.
Bobath, or neurodevelopmental therapy (NDT),1 is often described as “usual care” in neurorehabilitation despite evidence that more effective alternatives for improving motor function in cerebral palsy (CP) exist. A consensus clinical framework1,2 outlines 3 primary principles of NDT, which are (1) movement analysis of task performance, (2) interdependence of posture and movement, and (3) the role of sensory information in motor control.1,3 In practice, the elements of NDT are (1) therapist-controlled facilitation of movement via handling to provide optimal sensory input to improve postural control1,3 and (2) training movement quality to normalize motor patterns, currently termed regaining “typical motor behavior” and minimizing “atypical motor behavior.”1 This involves training movement quality rather than using compensatory or atypical strategies to complete a task,1 which is discouraged in NDT.
NDT has many highly cited publications,4 a testament to global uptake. NDT has a strong following among some practitioners internationally. Use of NDT varies; for example, 39% to 81% of clinicians in the United Kingdom,5 13% to 18%6 up to 60%7 in Canada, 7% to 54% in Norway,8 8% to 33% in Australia,9 3% of clinicians in 1 US hospital,10 and it is the standard of care in Korea.11
NDT has evolved considerably since its introduction,12 although this is not the case globally. In many settings, other contemporary approaches have been incorporated under the NDT banner. Theoretical underpinnings of NDT have been redefined to align with contemporary approaches moving from the traditional hierarchical model to a systems-based model of motor control.1 Aspects of NDT in clinical practice have been altered in response to evidence but practice is eclectic.12,13
A paradigm shift started in the 1990s14 away from “bottom-up” rehabilitation approaches, in which a therapist generates and facilitates normal movement patterns, as is seen in NDT, to “top-down” approaches in which the child sets goals and self-generates movements to actively practice and learn real-life tasks14,15 incorporating natural opportunities to learn.16 Top-down approaches are based on activity-dependent neuroplasticity mechanisms,15 different from bottom-up mechanisms. Training to improve impairments (eg, high tone, retained reflexes) and preparing the body for normal movement as a bottom-up approach17 has been replaced with training to improve a child’s activities and participation through learning, a top-down approach as conceptualized in the International Classification of Function, Disability and, Children and Youth Version (ICF-CY).18
Numerous systematic reviews have evaluated the effectiveness of NDT compared with an array of alternatives revealing no benefits of increased NDT dose,19 marginal benefits of NDT and casting over regular occupational therapy,20 and inconclusive findings for NDT versus physiotherapy in CP.21 Variability of NDT,1,12 insufficient evidence, and underdosed studies are posed as barriers to testing efficacy of NDT.
In the past decade, 2 systematic reviews of systematic reviews recommended ceasing NDT for children with CP to improve motor function, contracture, and self-care skills because effective top-down alternatives exist.22,23 With earlier diagnosis24 being standard of care in many countries, a shift toward early interventions that harness neuroplasticity based on infant self-generated movements is occurring. A recent clinical guideline has a strong recommendation against passive, therapist-controlled handling techniques for skill development during infancy,25 the critical time of brain development. However, NDT, which is ineffective, is still used with infants.7,11 Despite advances in neuroscience and knowledge of effective interventions, NDT remains widely used in infants and children with CP. Limited meta-analyses assessing the efficacy of NDT are available. Thus, there is a case for a broad-ranging review.
Objectives
Our objective was to determine the efficacy of NDT for any outcome in children and infants with CP and infants with a high risk of CP.
We hypothesized that (1) NDT is no more effective in improving outcomes in children and infants with CP than no intervention or passive approaches (hereby termed “control”), (2) NDT is less effective than activity-based approaches to improve motor function, (3) NDT is less effective than body function and structures-based approaches for body function and structures outcomes, (4) NDT is less effective than environment-based approaches on environment-based outcomes, (5) higher-dose NDT is no more effective than lower-dose NDT, and (6) NDT is not effective for improving motor function in infants with CP or risks for CP.
Methods
A systematic review and meta-analysis was conducted by using Cochrane methodology26 and reported by using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.27
Inclusion criteria using population, intervention, comparison, and outcome were (1) CP or high risk of CP based on diagnostic risk markers consistent with the era and >75% of participants <18 years, (2) intervention specified as Bobath, NDT, neurodevelopmental therapy, or “treatment,” (3) any comparison, (4) any outcome, (5) randomized controlled trial (RCT), and (6) published in English. No limits were placed on outcomes or date of publication. Exclusion criteria were (1) NDT versus NDT plus adjunct therapy (2) intervention not described as Bobath, NDT, neurodevelopmental therapy or treatment, (3) comparison of NDT at equal total dosage hours, but different frequencies, and (4) gray literature and conference abstracts. Search terms are presented in Supplemental Table 2.
Cumulative Index to Nursing & Allied Health Literature, Cochrane Library, Embase, and Medline databases were searched to March 10, 2021, with no lower date range. Studies were screened for eligibility by title and abstract by the first author and checked by 2 reviewers. Hand searching included the scanning of reference lists of all identified systematic reviews. Study characteristic extraction was divided between the authors and checked by the first author. Study quality was assessed at a domain level by using Cochrane Risk of Bias tool 2 (RoB-2)28 by 2 independent raters (divided between authors) and discrepancies were resolved by a third independent rater.
Coding for synthesis and meta-analysis was decided by group consensus. The International Classification of Function, Disability and Health, Children and Youth Version18 was used to code comparison interventions into activity, body structures and function, and environmental-based groups. Additional comparators considered were NDT versus control, higher- versus lower-dose NDT, and NDT versus any intervention in infants. Active (child-generated and -controlled) and passive (therapist-generated and -controlled) components of NDT and comparator interventions were extracted. Motor function was defined as motor development and the acquisition of motor skills.29
Inclusion criteria for meta-analysis included (1) 2 or more studies revealing similar outcomes, (2) mean and standard deviation outcome score and participant number could be extracted or calculated, (3) comparable outcome timeframe (long-term versus short-term), and (4) sufficient homogeneity of participants, interventions and outcomes to provide a meaningful summary.26 Meta-analysis exclusion criteria were (1) no common outcome and for dose comparator only (2) both groups of NDT <30 hours dosage to exclude underdosed studies. This dosage threshold was based on evidence suggesting 30 to 40 hours of activity-based interventions are required to improve motor function.20,30
Meta-analyses were conducted by using Review Manager 5.4.1. Estimates of effect were assessed by using the standardized mean difference between comparison groups of posttest or change scores, with change scores preferentially used in meta-analyses. Effect size was considered small (0.2), moderate (0.5), large (0.8) and very large (1.3).31 Random effects were used because of the varied nature of outcome measures with 95% confidence intervals (CI) for certainty and I2 for heterogeneity. Sensitivity analysis using fixed effects was also conducted. Clinically relevant subgroup analyses were conducted.
When mean and standard deviation were not available in text or from other systematic reviews, where possible, missing values were calculated by using REVMan using other variables. PlotDigitizer (version 2.6.9) was used to extract data from figures. If data were not retrievable using these methods, studies were excluded from the meta-analysis. If meta-analyses had considerable heterogeneity (I2 >75%)26 subanalyses were conducted to determine the heterogeneity source. Risk of publication bias was assessed by (1) visually inspecting funnel plots of each comparator meta-analysis for symmetry and (2) if >10 papers were included in a meta-analysis; Egger’s test was used to assess potential publication bias. Additionally, RoB-2 tool Domain 5 was used to assess reporting bias risk. The quality and strength of recommendations were further evaluated by using Grading of Recommendations Assessment, Development and Evaluation (GRADE).32 A protocol was not prepared.
Results
In total, 667 studies were screened and 35 studies met inclusion criteria with 2 studies33,34 written about a single cohort (Fig 1). Studies included 1332 participants (n = 578 infants <2 years, n = 754 children ≥2 years). Of these, 21 studies (including 667 participants) met inclusion for meta-analysis (Fig 1).27 Participants varied in terms of motor severity, motor type, and topography, reflecting known heterogeneity of children with CP.
Risk of Bias
Results of Individual Studies
Results of all studies are reported in Table 1. Of 35 studies, 6 of 35 (17%) favored NDT, 2 of 35 (6%) partially favored NDT, and 27 of 35 (77%) did not favor NDT (Table 1). Of 6 reports that favored NDT, 4 were assessed as high risk of bias. Active and passive components of interventions are described in Table 1. Motor function was the most common reported outcome (n = 28 studies)4,14,34–39,41–44,46,49–52,54–63,65 followed by general development (n = 4),34,50–52 reflex status (n = 4),55,57–59 cognition (n = 3),41,57,62 social development (n = 3),41,50,60 mobility/walking capacity (n = 3),14,39,40 quality of upper limb movement (n = 2),35,44 muscle length (n = 2),55,56 strength (n = 2),46,47 tone/spasticity (n = 2),58,59 mechanical efficiency (n = 2),36,38 sitting function (n = 2),48,61 and self-care (n = 2).49,60
Study Number . | Citation . | Design . | N . | Population: Diagnosis, Age, Motor Severity & Type of CP . | Intervention Elements . | Outcome Measures [Domain Measured] . | Total Dose . | Limitations . | Results . | Favors NDT . | |
---|---|---|---|---|---|---|---|---|---|---|---|
NDT vs Control | |||||||||||
1a | Carlsen 197552 | RCT 2 groups 1 = NDT 2 = Functional program immediate effect | 20 | CP 1–5 y Mild–Moderate Spastic [hemiplegia, diplegia, quadriplegia] Athetoid [dyskinetic] | NDT Passive: facilitation, sensory organization, postural stability Active: nil Functional Program Passive: unclear description Active: unclear description of self-care | Denver Bayley Motor Developmental Screening Test (DDST) [general development] Development Scale (BMS) [motor function] | 12 h NDT [intensity 1h, frequency 2/wk, duration 6 wk] | Low dose Unclear description of functional program Self-care training does not target movement | Improved motor (development age calculated using combination of DDST and BMS) favoring NDT | Yes | |
2 | d'Avignon 198153 | RCT 3 groups 1 = NDT 2 = Vojta 3 = Control Unclear length of effect measured | 30 | CP 2–6 y Mild–Severe Spastic [hemiplegia, diplegia, quadriplegia] Dyskinetic Ataxic | NDT Passive: unclear description Active: unclear description Vojta Passive: unclear description Active: unclear description Control “Less strictly performed physiotherapy” Passive: unclear description Active: unclear description | Rates of “uncomplicated CP” and normal development | Unclear | No baseline equivalence of risk factors for CP, no between group analysis Different intervention dose for infants with CP and normal outcome | No between group differences for rates of “uncomplicated” CP between Vojta, NDT & control groups | No | |
3a,b and 4b | Goodman 198534 Rothberg 1991c.33 | RCT 4 groups, including 2 groups appropriate for current question 1 = At-risk with NDT 2 = At-risk no therapy Immediate33 & long-term effect (5 y post intervention)32 | 80 | At risk for CP Very low birth wt 34 wk GA <1700g birth wt | NDT Passive: handling, normali zation of movement Active: nil Control No therapy | Griffiths 2 Development Quotient subscales [general development, including motor function] | 9h NDT [intensity 45 min, frequency 1/mo, duration 52 wk + daily home program] | Low dose High dropout rate Home program dose not reported Alternate not random assignment | No between group differences for improving development on the Griffiths, including locomotion for immediate or long-term outcomes | No | |
5a | Labaf 201554 | RCT 2 groups 1 = NDT 2 = Home program Immediate effect | 28 | CP 2–6 y Severity not listed Spastic [diplegia, quadriplegia] | NDT Passive: stretching, reduction of spasticity, facilitation Active: sitting on a chair, walking Home Program Passive: stretching, passive range of motion Active: active range of motion | GMFM-88 [gross motor function] | 36 h [intensity 1h, frequency 3/wk, duration 12 wk] | Multiple independent t tests conducted of GMFM-88 domains Possible reporting error on GMFM-88 | Improved laying, rolling & sitting dimensions on GMFM favoring NDT No between group differences for walking, running, jumping dimensions on GMFM | Partially | |
6a | Law 199735 | RCT 2 groups with cross over 1 = Casting + intensive NDT 2 = Regular OT Immediate & long-term (2 mo) effect | 50 | CP 1.5–4 y Moderate to severe upper extremity involvement Spastic [hemiplegia, diplegia (with upper limb involvement), quadriplegia] | NDT Passive: facilitation & handling Active: nil Regular OT Passive: unclear description Active: unclear description, task analysis was used but the treatment approach is not described | Peabody Fine Motor Scales [fine motor function] QUEST [quality of upper extremity movement] COPM [parent perception of hand function] | 80 h NDT [intensity 45 min, frequency 2/wk, duration 16 wk + 30 min/d home program] 12 h OT [intensity 45 min, frequency 1/wk, duration 16 wk] | Crossover design limits power. Poor description of regular OT intervention Vast dose differential favoring NDT but no between group differences | No between group differences on any measure | No | |
7b | Piper 198657 | RCT 2 groups 1 = NDT 2 = No therapy Immediate effect | 134 | At-risk for CP NICU graduates (<1500 g birth wt, asphyxia, seizures, CNS dysfunction with abnormal EEG) 25–41wk GA | NDT Passive: handling, facilitation & exercises (not defined) + parent coaching in handling Active: nil Control No therapy | Wolanski Gross Motor Evaluation Milani-Comparetti Motor Development Test [motor function] Griffiths Mental Development Scale [cognition] Wilson Developmental Reflex Profile [reflex status] | 30h NDT [intensity 1 h, frequency 1/wk, duration 12 wk + intensity 1h, frequency 0.5×/wk, duration 36 wk] | Risk for CP not clearly defined both groups, i.e. infants may have been on a trajectory to normal outcome and not needed treatment Vast dose differential favoring NDT but no between group differences | No between group differences for: motor function on Wolanski Gross Motor & Milani-Comparetti Motor Development Test Overall development on Griffith or neurologic status on Wilson Developmental Reflex Profile | No | |
8 | Rothman 197845 | RCT 2 groups 1 = NDT respiratory exercises 2 = No therapy Immediate effect | 10 | CP 5–8 y GMFCS I&II (ambulant without assistive devices) Spastic [diplegia] | NDT Passive: nil Active: diaphragmatic breathing, expiratory activity with targets, inspiration & expansion, abdominal strengthening exercises Control No therapy | Mean vital capacity 1-s forced expiratory vol [respiratory function] | 6h NDT [intensity 5–7 min, frequency 7/wk, duration 8 ks] | Small sample Note: all the exercises in this NDT program were child active, no passive elements | Improved vital capacity on spirometry favoring NDT | Yes | |
9 | Sommerfeld 198155 | RCT 3 groups 1 = NDT direct 2 = NDT supervised 3 = No therapy Unable to determine likely immediate effect | 19 | CP Intellectual disability 3–22 y Mild–Severe Spastic [hemiplegia, diplegia, quadriplegia] Athetoid [Dyskinetic] Ataxic | NDT Direct Passive: inhibition of reflexes, facilitation, normalization of tone, range of motion and positioning Active: nil NDT Supervised Passive: inhibition of reflexes, facilitation, normalization of tone, range of motion & positioning Active: nil | Wilson Developmental Reflex Test [reflex status] Wayne County Intermediate School District's (WCISD) Gross Motor Evaluation [gross motor function] Range of Motion Scale [muscle length] | Unknown Duration not stated precluding calculation NDT direct [intensity 30 min, frequency 2×/wk] NDT Supervised [intensity 2 h, frequency 5×/wk] | Probably underpowered, no sample size calculations Motor outcome measure not reliable or standardized | No between group differences for improving gross motor skills on WCISD Gross Motor Evaluation for NDT in either format compared with no therapy | No | |
10 | Wright 197356 | RCT 3 groups 1 = NDT long duration 2 = NDT short duration 3 = No therapy Immediate effect | 47 | CP 1–6 y Severity difficult to determine Spastic [hemiplegia, diplegia, quadriplegia] | NDT Passive: normalized tone, normalized movement Active: nil | Motor function assessment83 Included (a) function, (b) range of movement and (c) the presence or absence of the primary automatic reflexes [motor function] Passive range of motion [muscle length] | Dose unable to be calculated Long duration 12 mo Short duration 6 mo Ratio of therapy by groups 2:1:0 favoring NDT | High dropout rate Small sample size Motor outcome measure not reliable or standardized | No between group differences for motor function between NDT long and short duration and no therapy groups No change in passive range of movement between NDT long and short duration and no therapy groups | No | |
NDT vs Activity-Based Approaches | |||||||||||
11a | Al-Oraibi 201137 | RCT 2 groups 1 = CIMT 2 = NDT Immediate effect | 20 | CP 3–5 y Severity not listed Spastic [hemiplegia] | CIMT Passive: nil Active: manipulation task-specific practice, with incremented challenge. Parent education for home practice at home while wearing constraint NDT Passive: weightbearing and facilitation of arm movement. Active: nil | AHA [hand function] | 112 h CIMT [intensity 2 h, frequency 7×/wk, duration 8 wk] 16 h NDT [intensity 2 h, frequency 1×/wk, duration 8 wk] | Interventions not dose matched High drop outs (reasons accounted for) CIMT group slightly younger Difference in baseline AHA scores | Group effect for improving hand function on AHA favoring CIMT | No | |
12a | Bar-Haim 201038 | RCT 2 groups 1 = Motor learning coaching 2 = NDT Immediate & long-term effect | 78 | CP 6–12 y GMFCS II-III Spastic [diplegia, quadriplegia] Mixed type | Motor Learning Passive: nil Active: child-set goals, practice of real-life goal tasks, feedback on performance, variability NDT Passive: stretching, normalizing tone, facilitation of movement Active: walking, sit-to-stand | GMFM-66 [gross motor function] Mechanical efficiency during stair climbing Quantitative physiologic measure of coordination [coordination] | 36h [intensity 1 h, frequency 3×/wk, duration 12 wk] | Low dose Small sample size Lack of concealed allocation | Improved gross motor function on the GMFM-66 favoring the motor learning group | No | |
13a | Bleyenheuft 201539 | RCT 2 groups 1 = HABIT-ILE 2 = NDT (delayed HABIT-ILE) Immediate effect | 24 | CP 6–13 y GMFCS I-II, MiniMACS I-III Spastic [hemiplegia] | HABIT-ILE Passive: nil Active: graded bimanual and gross motor functional task training, active training of posture control in sitting and standing, child and parent set goals, child problem solving, repetitive upper limb movements NDT Passive: remediation of impairments, correcting movement patterns. Active: functional training using nonmotor training principles | Primary AHA [hand function] 6MWT [walking capacity] Multiple secondary outcome measures | 90 h [intensity 9 h, frequency daily, duration 10 d] 80 h (average) conventional therapy [intensity 1–5 h/wk, frequency unable to determine, duration 20 wk] | Difference in dose favoring HABIT-ILE (80h v 90h average), but reasons for lower dose accounted for | Between group difference for hand function (AHA) and walking (6MWD) favoring HABIT-ILE. | No | |
14a | Choi 201148 | RCT 2 groups 1 = Task-oriented sitting balance 2 = NDT Immediate effect | 10 | CP 2–9 y Severity not listed Spastic [diplegia] | Task-Oriented Training Passive: unclear description: stretching of pelvis, inhibition of high tone, Active: unclear description listed as motor training approach: strength training trunk and lower limb, task practice sitting, standing, active balance on a ball. NDT Passive: no description Active: no description | GMFM sitting dimension [sitting function] Electro myography (EMG) [rectus abdominus and erector spinae muscle activity] | 15 h Task-oriented approach [intensity 30 m, frequency 5/wk, duration 6 wk] NDT: no dose description | Unclear description both interventions. No calculation to justify small sample size | No between group differences for improving GMFM sitting sub scale or muscle activity on EMG. | No | |
15a | Ketelaar 200114 | RCT 2 groups 1 = Functional training 2 = NDT & Vojta Immediate & long-term (6 & 12mo) effect | 55 | CP 2–7 y Mild–Moderate Spastic [hemiplegia, diplegia, quadriplegia] | Functional Training Passive: nil Active: child generated movement solutions to reach goals, repetitive task-specific practice NDT Passive: normalized movement, facilitation, inhibition abnormal movement Active: nil | GMFM-88 standing & walking running & jumping dimensions [mobility function] PEDI [motor function] | 26 h both groups [intensity 1 h, frequency 1/wk, duration 26 wk] | Measures completed post randomization | Improved functional skills on the PEDI favoring Functional Training group No between group differences for gross motor skills on GMFM dimensions | No | |
16a | Ko 202049 | RCT 2 groups 1 = Group-based task -oriented training 2 = NDT Immediate effect | 18 | CP 4–7.5 y GMFCS I-III Spastic [unilateral & bilateral] | Group Task-Oriented Training Passive: nil Active: functional child goal-directed, activity interventions based on motor learning, feedback on performance. NDT Passive: unclear description: normalization of quality of movement, in line with NDT Active: unclear description, no active components described | GMFM-88 [gross motor function] BOT-2 manual dexterity subscale [fine motor function] PEDI [self-care, mobility] | 16 h both groups [intensity 1 h, frequency 2/wk, duration 8 wk] | Lack of concealed group allocation Control of other school and community activities not factored into intensity Between group differences unable to be measured long-term as no follow up of comparator group | Significant improvement in GMFM-88 (standing and walking/running/jumping dimension) Improved manual dexterity on BOT-2 and social function on PEDI favoring task-oriented training group No between group differences on any outcome measure | No | |
17a,b | Palmer 198841 | RCT 2 groups 1 = Infant stimulation 2 = NDT Immediate effect | 48 | CP 12–19 mo Mild–Severe Spastic [diplegia] | Infant Stimulation Passive: nil Active: active practice of motor, cognitive and language tasks using the Learning Games curriculum NDT Passive: improvement of righting & equilibrium reactions Active: nil | BMS [motor function] Bayley Scales Mental quotient [cognition] Vineland Social Maturity Scale [social development] | 12h infant stimulation [intensity 1 h, frequency 0.5/wk, duration 26 wk] 20 h NDT [intensity 1 h, frequency 5/wk, duration until sitting achieved] | NDT not well described Higher dose favoring NDT | Improved motor skills, walking and cognitive development favoring infant stimulation, despite NDT being offered at a higher dose No between group difference for social development | No | |
18 | Sah 201961 | RCT 2 groups 1 = Task oriented NDT (TOA-NDT) 2 = conventional physiotherapy Immediate effect | 44 | CP 7–15 y GMFCS II-III Spastic [diplegia] | Task-Oriented Activities Based on NDT (TOA-NDT) Passive: facilitation for optimal trunk alignment Active: trunk activation in multiple planes in sitting and standing using hands-on facilitation. Reaching during activity (popping bubbles, reach for balls, transferring) Conventional Physiotherapy Passive: passive stretch and range of movement of lower limbs Active: pegboard reaching task, standing on balance board, ball throwing | GMFM-88 [gross motor function] Postural Assessment Scale [postural control] Pediatric Balance Scale [dynamic balance ability] Trunk Impairment Scale [sitting balance function] | 36 h TOA-NDT [intensity 1h, frequency 6/wk, duration 6 wk] 36 h Conventional Physio therapy [intensity 1 h, frequency 6/wk, duration 6 wk] | Nonblinded assessment of outcomes | Improvement in gross motor function and dynamic balance skills favoring TOA-NDT group over passive stretch group No between group differences for postural control and dynamic sitting balance | Yes | |
19a | Salem 200940 | RCT 2 groups 1 = Task-orientated training 2 = NDT Immediate effect | 10 | CP 4–12 y GMFCS I-III Spastic [diplegia, quadriplegia] | Task-Oriented Training Passive: nil Active: task-orientated strength training, practice of functional tasks NDT Passive: facilitation, normalization of movement Active: nil | GMFM-88 standing and walking dimensions [mobility] TUG [mobility] | 10 h [intensity 1h, frequency 2/wk, duration 5 wk] | No calculation to justify small sample size | Improved gross motor skills in standing and walking on the GMFM favoring the task-orientated training Improved mobility speed on TUG favoring the task-orientated training group | No | |
NDT vs Body Function & Structures-Based Approaches | |||||||||||
20a | Avcil 202046 | RCT 2 groups 1 = Video game-based therapy (VGBT) 2 = NDT immediate effect | 30 | CP 10 y (mean age) GMFCS I-IV Spastic [hemiplegia, diplegia] Dyskinesia | VGBT Passive: tone regulation, sensory support Active: simulated sports (tennis and boxing), progressive repetitive wrist and hand games, grip development games, feedback via video hand controller NDT Passive: tone regulation, sensory support, facilitation for normalized movement Active: dressing, eating, increased complexity of activities | Minnesota Manual Dexterity Test (MMDT) [manual dexterity] Childhood Health Assessment Questionnaire [functional ability] Duruoz Hand Index [fine motor function] Dynamometry [grip and pinch strength] | 24 h both groups [intensity 1 hr, frequency 3/wk, duration 8 wk] | Motor severity different between groups at baseline Unable to assess tone outcomes as low numbers of infants displayed spasticity | Improved manual dexterity favoring VGBT group for hemiplegia, improved grip strength in both groups | No | |
21a | Bar-Haim 200636 | RCT 2 groups 1 = Adeli Suit 2 = NDT Immediate & long-term (9 mo) effect | 24 | CP 5–12 y GMFCS II-IV Spastic [diplegia, triplegia, quadriplegia] Ataxic Mixed | Adeli Suit Passive: massage, stretching, suit wearing Active: walking on varied terrains, sit-to-stand, ball play, trampoline jumping, stair-climbing, ladder-climbing NDT Passive: stretching, normalizing tone, facilitation of movement Active: walking, sit-to-stand | GMFM-66 [gross motor function] Mechanical efficiency during stair climbing | 40 h both groups [intensity 2 h, frequency 5×/wk, duration 4 wk] | Short duration intervention | Improved mechanical efficiency during stair climbing favoring the suit group No difference between groups for gross motor function | No | |
22a | Batra 201559 | RCT 2 groups 1 = Neuro-facilitation of Developmental Reaction (NFDR) 2 = NDT Immediate effect | 30 | CP IQ ≥ 55 4–7 y Mild–Moderate Spastic [topography unclear] | NFDR Passive: preparation for movement, facilitation, vestibular input, normalization of tone and reflexes Active: perturbation to elicit adaptive postural reactions, training motor control NDT Passive: positioning, handling, stretching, inhibition and facilitation techniques, weight-bearing Active: nil | GMFM-88[gross motor function] Modified Ashworth Scale [muscle tone, spasticity] Primitive Reflex Intensity Grading Score [reflex status] | 24 h both groups [intensity 40 min, frequency 3×/wk, duration 12 wk] | Interventions have similar characteristics No calculation to justify small sample size Report on change in GMFCS levels favoring NFDR which seems unfeasible | Reduced spasticity in select muscle groups and improved gross motor function and GMFCS levels favoring NFDR No change in reflex status between groups | No | |
23a,b | Batra 201258 | RCT 2 groups 1 = NFDR 2 = NDT Immediate effect | 30 | CP 0.5–2 y Mild–Moderate Spastic [topography unclear] | NFDR Passive: preparation for movement, facilitation, vestibular input Active: perturbation to elicit postural reactions NDT Passive: positioning, handling, stretching, weight-bearing Active: nil | GMFM-88[gross motor function] Modified Ashworth Scale [muscle tone, spasticity] Primitive Reflex Intensity Grading Score [reflex status] | 24 h both groups [intensity 40 min, frequency 3×/wk, duration 12 wk] | Small sample size Interventions are similar in many elements | Reduced spasticity in select muscle groups and improved gross motor function favoring NFDR | No | |
24a | Nam 201747 | RCT 2 groups 1 = Dynamic balance training 2 = NDT Immediate effect | 15 | CP 14 y (mean age) GMFCS I-III Spastic [diplegia] | Dynamic Balance Passive: nil Active: active balance on a balance trainer device, where the child’s load forces to actively maintain balance were recorded NDT Passive: unclear description Active: unclear description | Muscle thickness (on ultrasound) [proxy for muscle strength] | 9 h [intensity 30 min, frequency 3×/wk, duration 6 wk] | No measurement of the functional implications of this treatment | Between group difference of muscle thickness favoring dynamic balance training | No | |
25b | Scherzer 197660 | RCT 2 groups 1 = Passive stretching 2 = NDT Immediate effect | 24 | CP, high risk CP <18 mo Mild–Severe Spastic Athetoid [dyskinetic] Ataxic Mixed | Passive Stretch Passive: passive range of motion Active: nil NDT Passive: positioning to inhibit abnormal reflexes, facilitation, parents trained in techniques Active: movement to inhibit abnormal reflexes, stimulation of movement | Motor Development Evaluation Form [motor function] Social Maturation questionnaire [social development] Home management questionnaire [self-care] | Unable to calculate dose [intensity: not listed, frequency 2×/wk, duration: mean 12.5 mo] | Underpowered sample size Non standardized outcome measures Between group difference not measured | Improvement in motor status and social maturation after NDT | Yes | |
26a | Shamsoddini 201065 | RCT 2 groups 1 = Sensory integration (SI) 2 = NDT Immediate effect | 22 | CP 2–6 y Severity not listed Spastic [diplegia, quadriplegia] | NDT Passive: stretching, reducing spasticity, facilitation, normalized movement Active: nil SI Passive: stretching, reducing spasticity, facilitation, normalized movement Active: visual motor coordination, ocular pursuit activities, pegboard activities, turning left & right | GMFM-88 [gross motor function] | 36–54 h [intensity 1–1.5 h, frequency 3×/wk, duration 12 wk] | Possible reporting error No calculation to justify small sample size | Improved lying, sitting, crawling motor skills on GMFM-88 favoring SI | No | |
NDT vs Environmental-Based Approaches | |||||||||||
27b | Hanzlik 198962 | RCT 2 groups 1 = Parent coaching 2 = NDT Immediate effect | 20 | CP & developmental delay 1–2 y Mild–Severe Spastic [hemiplegia, diplegia, quadriplegia] | Parent Coaching Passive: adaptive seating for infant Active: coaching in play responsivity, reduced physical contact which was converted to face-to-face contact + communication NDT Passive: facilitation, normalized tone, normalized movement Active: nil | Modified Milani-Comparetti and Gidoni Scale of Gross Motor Development [gross motor function] Bayley Scales of Mental Development [cognition] Maternal Observation Interview [behavioral styles] Hollingshead Four-Factor Index of Social Position [socioeconomic status] | 1 h [intensity: 1 h coaching or NDT + home practice dose unspecified] | Brief descriptions of the intervention Low dose both groups | Improved infant responsiveness favoring parent coaching group No between group differences for independent play | No | |
28b | Girolami 199463 | RCT 3 groups 1 = NDT 2 = Nonspecific handling 3 = Term controls (no therapy) Immediate effect | 27 | Preterm infants at risk for CP, 34 wk GA 0–1 y Term-born controls Severity & topography not clear | Nonspecific Handling Passive: positioning without NDT handling Active: nil NDT Passive: handling, facilitation Active: active postures during handling | Neonatal Behavioral Assessment Scale (NBAS) motor cluster [motor function] Supplemental Motor Test [motor control] | 5 h [intensity 15 min, frequency 14/wk, duration 1–2 wk] | High attrition rates Small sample size Risk for CP not clearly defined, i.e. these preterm infants may have been on a trajectory to a normal outcome and thus not needed treatment | Improved motor performance on the NBAS favoring NDT No between group difference for tone, behavioral state, reflexes & regulation | Partially | |
NDT Higher Dose vs NDT Lower Dose | |||||||||||
29 | Bower 199642 | RCT 4 groups 1 = Lower dose NDT + aims 2 = Higher dose NDT + aims 3 = Lower dose NDT + goals 4 = Higher dose NDT + goals Immediate effect | 44 | CP 3–11 y Moderate– Severe Spastic [quadriplegia] | NDT Passive: unclear description Active: unclear description | GMFM-88 [gross motor function] | 2 h mean lower dose (aims + goals group) [duration 2 wk] 9 h mean higher dose (aims + goals group) [duration 2 wk] | Low dose in both groups within the context of neuroplasticity | No between group differences for lower versus higher dose group for gross motor function Improved gross motor skills on the GMFM favoring goals over aims | No | |
30 | Bower 200143 | RCT 4 groups 1 = Lower dose NDT + aims 2 = Higher dose NDT + aims 3 = Lower dose NDT + goals 4 = Higher dose NDT + goals Immediate effect | 56 | CP 3–12 y GMFCS III-V Spastic [bilateral] | NDT Passive: stretching, handling, positioning, equipment, orthoses, casting Active: muscle strengthening, active movement, gross motor skills training | GMFM-88 [gross motor function] Gross Motor Performance Measure (GMPM) [gross motor performance] MPOC-20 [parent perception of care giving] | 36 h median lower dose [intensity 1 h, frequency 0.5/wk, duration 72 wk] 112 h median higher dose [intensity 5 h, frequency 1/wk, duration 26 wk + intensity 1 h, frequency 0.5×/wk, duration 46 wk] | These doses would be considered to be in the therapeutic range but are over a long duration (18 mo) Multiple treating therapists | No between group differences for aims versus goals or lower dose v higher dose for gross motor skills on GMFM or GMPM | No | |
31a | Law 199144 | RCT 4 groups, 2 groups relevant to dose question 1 = Lower dose (regular NDT) 2 = Higher dose (intensive NDT) Immediate & long term (3 mo) effect | 36 | CP 1.5–8 y Severity not listed Spastic [hemiplegia, quadriplegia] | NDT Passive: weight-bearing, facilitation Active: reaching & grasping, bilateral co-ordination | Peabody fine motor scales [fine motor function] QUEST [quality of upper extremity movement] | 39 h lower dose NDT [intensity 45 min, frequency 1/wk + home program 30 min 3×/wk, duration 26 wk] 130 h higher dose NDT [Intensity 45min Frequency 2/wk + home program 30min 7×/wk Duration 26wk] | Small sample size leading to underpowered study Variation in dose within groups | No between group difference for fine motor function on PDMS or quality of movement on QUEST | No | |
32b | Mayo 199164 | RCT 2 groups 1 = Lower dose NDT 2 = Higher dose NDT Immediate effect | 29 | CP 0–1.5 y Moderate– Severe Spastic [hemiplegia, diplegia, quadriplegia] | NDT Passive: unclear description Active: unclear description | Aggregate of 7 instruments: (reflex activity, postural reactions, Wolanski Gross Motor Evaluation, [gross motor function], fine motor, Bayley mental scale, Abnormal movement scale, activities of daily living) | 6 h median lower dose [intensity 1 h, frequency 1/mo, duration 26 wk + unspecified intensity for home program] 26 h median higher dose [intensity 1 h, frequency 1/wk, duration 26 wk + unspecified intensity for home program] | Low dose in both groups within the context of neuroplasticity High rate of no CP by end of study (31%) Reported aggregate score with 7 instruments meaning score could artificially rise if the child made improvements on a test in which they had no impairments | Improved skills on aggregate of 7 instruments favoring higher dose NDT | Yes | |
33a | Tsorlakis 20044 | RCT 2 groups 1 = Lower dose NDT 2 = Higher dose NDT Immediate effect | 34 | CP 3–14 y GMFCS I-III Spastic [hemiplegia, diplegia, quadriplegia] | NDT Passive: unclear description Active: unclear description Based on Bobath principles 1994–2001 era, suggesting it probably included: handling, facilitation, normalization of movement | GMFM-66 [gross motor function] | 32 h median lower dose [intensity 1 h, frequency 2/mo, duration 16 wk] 80 h median higher dose [intensity 1 h, frequency 5/wk, duration 16 wk] | Unclear description of intervention Underpowered study (did not meet calculated sample size) | Improved gross motor skills on the GMFM favoring higher dose NDT. Results were larger in younger children | Yes | |
34b | Weindling 199650 | RCT 2 groups 1 = Lower dose NDT (delayed physiotherapy) 1 = Higher dose NDT (early physiotherapy) Immediate & long-term (at age 30 mo) effect | 110 | Infants at risk for CP on neuroimaging, included preterm and term born infants CP (n = 45) 0–1 y Severity not clear Spastic [hemiplegia, diplegia, quadriplegia] | NDT Passive: handling, positioning, passive limb movement Active: holding feeder cup | Griffiths Developmental Quotient [general development] included analysis of sub scales: Locomotor Personal Social Performance Hearing– Speech Eye–Hand Mental Range | 16 h lower dose [intensity not listed, frequency 1/wk, duration 16 wk] 35–52 h higher dose [intensity: not listed, frequency 1/wk, duration 35–52 wk] Doses estimated on 1 h/session | Dose difficult to calculate as intensity not listed No stratification for motor severity, leading to nonbaseline equivalence for severity favoring higher dose group Griffiths locomotor scale not valid for severe motor impairment Only 50% of infants had CP outcome | No between group difference at 12 or 30 mo for motor development or total developmental quotient on Griffiths | No | |
35a,b | Weindling 200751 | RCT 2 groups 1 = Lower dose NDT (standard care physiotherapy) 2 = Higher dose NDT (NDT + NDT therapy given by physiotherapy assistant Immediate & long-term (6 & 12 mo post intervention) effect | 76 | CP <4 y Severity not listed Spastic [hemiplegia, diplegia, quadriplegia] | NDT Passive: normalization of posture and movements, movement facilitation. Active: nil | GMFM [gross motor function] Griffiths [general development] Vineland [adaptive functioning] Various parent, home ecology measures | 32 h lower dose (estimate) [intensity & frequency not standardized] 60 h higher dose = 34 h standard NDT physio [intensity & frequency not standardized] + 26 h physio assistant [intensity 1 h, intensity 1/wk, duration 6 mo] | Dose not able to be estimated (estimate from number of contacts) | No between group difference between higher and lower intensity NDT | No |
Study Number . | Citation . | Design . | N . | Population: Diagnosis, Age, Motor Severity & Type of CP . | Intervention Elements . | Outcome Measures [Domain Measured] . | Total Dose . | Limitations . | Results . | Favors NDT . | |
---|---|---|---|---|---|---|---|---|---|---|---|
NDT vs Control | |||||||||||
1a | Carlsen 197552 | RCT 2 groups 1 = NDT 2 = Functional program immediate effect | 20 | CP 1–5 y Mild–Moderate Spastic [hemiplegia, diplegia, quadriplegia] Athetoid [dyskinetic] | NDT Passive: facilitation, sensory organization, postural stability Active: nil Functional Program Passive: unclear description Active: unclear description of self-care | Denver Bayley Motor Developmental Screening Test (DDST) [general development] Development Scale (BMS) [motor function] | 12 h NDT [intensity 1h, frequency 2/wk, duration 6 wk] | Low dose Unclear description of functional program Self-care training does not target movement | Improved motor (development age calculated using combination of DDST and BMS) favoring NDT | Yes | |
2 | d'Avignon 198153 | RCT 3 groups 1 = NDT 2 = Vojta 3 = Control Unclear length of effect measured | 30 | CP 2–6 y Mild–Severe Spastic [hemiplegia, diplegia, quadriplegia] Dyskinetic Ataxic | NDT Passive: unclear description Active: unclear description Vojta Passive: unclear description Active: unclear description Control “Less strictly performed physiotherapy” Passive: unclear description Active: unclear description | Rates of “uncomplicated CP” and normal development | Unclear | No baseline equivalence of risk factors for CP, no between group analysis Different intervention dose for infants with CP and normal outcome | No between group differences for rates of “uncomplicated” CP between Vojta, NDT & control groups | No | |
3a,b and 4b | Goodman 198534 Rothberg 1991c.33 | RCT 4 groups, including 2 groups appropriate for current question 1 = At-risk with NDT 2 = At-risk no therapy Immediate33 & long-term effect (5 y post intervention)32 | 80 | At risk for CP Very low birth wt 34 wk GA <1700g birth wt | NDT Passive: handling, normali zation of movement Active: nil Control No therapy | Griffiths 2 Development Quotient subscales [general development, including motor function] | 9h NDT [intensity 45 min, frequency 1/mo, duration 52 wk + daily home program] | Low dose High dropout rate Home program dose not reported Alternate not random assignment | No between group differences for improving development on the Griffiths, including locomotion for immediate or long-term outcomes | No | |
5a | Labaf 201554 | RCT 2 groups 1 = NDT 2 = Home program Immediate effect | 28 | CP 2–6 y Severity not listed Spastic [diplegia, quadriplegia] | NDT Passive: stretching, reduction of spasticity, facilitation Active: sitting on a chair, walking Home Program Passive: stretching, passive range of motion Active: active range of motion | GMFM-88 [gross motor function] | 36 h [intensity 1h, frequency 3/wk, duration 12 wk] | Multiple independent t tests conducted of GMFM-88 domains Possible reporting error on GMFM-88 | Improved laying, rolling & sitting dimensions on GMFM favoring NDT No between group differences for walking, running, jumping dimensions on GMFM | Partially | |
6a | Law 199735 | RCT 2 groups with cross over 1 = Casting + intensive NDT 2 = Regular OT Immediate & long-term (2 mo) effect | 50 | CP 1.5–4 y Moderate to severe upper extremity involvement Spastic [hemiplegia, diplegia (with upper limb involvement), quadriplegia] | NDT Passive: facilitation & handling Active: nil Regular OT Passive: unclear description Active: unclear description, task analysis was used but the treatment approach is not described | Peabody Fine Motor Scales [fine motor function] QUEST [quality of upper extremity movement] COPM [parent perception of hand function] | 80 h NDT [intensity 45 min, frequency 2/wk, duration 16 wk + 30 min/d home program] 12 h OT [intensity 45 min, frequency 1/wk, duration 16 wk] | Crossover design limits power. Poor description of regular OT intervention Vast dose differential favoring NDT but no between group differences | No between group differences on any measure | No | |
7b | Piper 198657 | RCT 2 groups 1 = NDT 2 = No therapy Immediate effect | 134 | At-risk for CP NICU graduates (<1500 g birth wt, asphyxia, seizures, CNS dysfunction with abnormal EEG) 25–41wk GA | NDT Passive: handling, facilitation & exercises (not defined) + parent coaching in handling Active: nil Control No therapy | Wolanski Gross Motor Evaluation Milani-Comparetti Motor Development Test [motor function] Griffiths Mental Development Scale [cognition] Wilson Developmental Reflex Profile [reflex status] | 30h NDT [intensity 1 h, frequency 1/wk, duration 12 wk + intensity 1h, frequency 0.5×/wk, duration 36 wk] | Risk for CP not clearly defined both groups, i.e. infants may have been on a trajectory to normal outcome and not needed treatment Vast dose differential favoring NDT but no between group differences | No between group differences for: motor function on Wolanski Gross Motor & Milani-Comparetti Motor Development Test Overall development on Griffith or neurologic status on Wilson Developmental Reflex Profile | No | |
8 | Rothman 197845 | RCT 2 groups 1 = NDT respiratory exercises 2 = No therapy Immediate effect | 10 | CP 5–8 y GMFCS I&II (ambulant without assistive devices) Spastic [diplegia] | NDT Passive: nil Active: diaphragmatic breathing, expiratory activity with targets, inspiration & expansion, abdominal strengthening exercises Control No therapy | Mean vital capacity 1-s forced expiratory vol [respiratory function] | 6h NDT [intensity 5–7 min, frequency 7/wk, duration 8 ks] | Small sample Note: all the exercises in this NDT program were child active, no passive elements | Improved vital capacity on spirometry favoring NDT | Yes | |
9 | Sommerfeld 198155 | RCT 3 groups 1 = NDT direct 2 = NDT supervised 3 = No therapy Unable to determine likely immediate effect | 19 | CP Intellectual disability 3–22 y Mild–Severe Spastic [hemiplegia, diplegia, quadriplegia] Athetoid [Dyskinetic] Ataxic | NDT Direct Passive: inhibition of reflexes, facilitation, normalization of tone, range of motion and positioning Active: nil NDT Supervised Passive: inhibition of reflexes, facilitation, normalization of tone, range of motion & positioning Active: nil | Wilson Developmental Reflex Test [reflex status] Wayne County Intermediate School District's (WCISD) Gross Motor Evaluation [gross motor function] Range of Motion Scale [muscle length] | Unknown Duration not stated precluding calculation NDT direct [intensity 30 min, frequency 2×/wk] NDT Supervised [intensity 2 h, frequency 5×/wk] | Probably underpowered, no sample size calculations Motor outcome measure not reliable or standardized | No between group differences for improving gross motor skills on WCISD Gross Motor Evaluation for NDT in either format compared with no therapy | No | |
10 | Wright 197356 | RCT 3 groups 1 = NDT long duration 2 = NDT short duration 3 = No therapy Immediate effect | 47 | CP 1–6 y Severity difficult to determine Spastic [hemiplegia, diplegia, quadriplegia] | NDT Passive: normalized tone, normalized movement Active: nil | Motor function assessment83 Included (a) function, (b) range of movement and (c) the presence or absence of the primary automatic reflexes [motor function] Passive range of motion [muscle length] | Dose unable to be calculated Long duration 12 mo Short duration 6 mo Ratio of therapy by groups 2:1:0 favoring NDT | High dropout rate Small sample size Motor outcome measure not reliable or standardized | No between group differences for motor function between NDT long and short duration and no therapy groups No change in passive range of movement between NDT long and short duration and no therapy groups | No | |
NDT vs Activity-Based Approaches | |||||||||||
11a | Al-Oraibi 201137 | RCT 2 groups 1 = CIMT 2 = NDT Immediate effect | 20 | CP 3–5 y Severity not listed Spastic [hemiplegia] | CIMT Passive: nil Active: manipulation task-specific practice, with incremented challenge. Parent education for home practice at home while wearing constraint NDT Passive: weightbearing and facilitation of arm movement. Active: nil | AHA [hand function] | 112 h CIMT [intensity 2 h, frequency 7×/wk, duration 8 wk] 16 h NDT [intensity 2 h, frequency 1×/wk, duration 8 wk] | Interventions not dose matched High drop outs (reasons accounted for) CIMT group slightly younger Difference in baseline AHA scores | Group effect for improving hand function on AHA favoring CIMT | No | |
12a | Bar-Haim 201038 | RCT 2 groups 1 = Motor learning coaching 2 = NDT Immediate & long-term effect | 78 | CP 6–12 y GMFCS II-III Spastic [diplegia, quadriplegia] Mixed type | Motor Learning Passive: nil Active: child-set goals, practice of real-life goal tasks, feedback on performance, variability NDT Passive: stretching, normalizing tone, facilitation of movement Active: walking, sit-to-stand | GMFM-66 [gross motor function] Mechanical efficiency during stair climbing Quantitative physiologic measure of coordination [coordination] | 36h [intensity 1 h, frequency 3×/wk, duration 12 wk] | Low dose Small sample size Lack of concealed allocation | Improved gross motor function on the GMFM-66 favoring the motor learning group | No | |
13a | Bleyenheuft 201539 | RCT 2 groups 1 = HABIT-ILE 2 = NDT (delayed HABIT-ILE) Immediate effect | 24 | CP 6–13 y GMFCS I-II, MiniMACS I-III Spastic [hemiplegia] | HABIT-ILE Passive: nil Active: graded bimanual and gross motor functional task training, active training of posture control in sitting and standing, child and parent set goals, child problem solving, repetitive upper limb movements NDT Passive: remediation of impairments, correcting movement patterns. Active: functional training using nonmotor training principles | Primary AHA [hand function] 6MWT [walking capacity] Multiple secondary outcome measures | 90 h [intensity 9 h, frequency daily, duration 10 d] 80 h (average) conventional therapy [intensity 1–5 h/wk, frequency unable to determine, duration 20 wk] | Difference in dose favoring HABIT-ILE (80h v 90h average), but reasons for lower dose accounted for | Between group difference for hand function (AHA) and walking (6MWD) favoring HABIT-ILE. | No | |
14a | Choi 201148 | RCT 2 groups 1 = Task-oriented sitting balance 2 = NDT Immediate effect | 10 | CP 2–9 y Severity not listed Spastic [diplegia] | Task-Oriented Training Passive: unclear description: stretching of pelvis, inhibition of high tone, Active: unclear description listed as motor training approach: strength training trunk and lower limb, task practice sitting, standing, active balance on a ball. NDT Passive: no description Active: no description | GMFM sitting dimension [sitting function] Electro myography (EMG) [rectus abdominus and erector spinae muscle activity] | 15 h Task-oriented approach [intensity 30 m, frequency 5/wk, duration 6 wk] NDT: no dose description | Unclear description both interventions. No calculation to justify small sample size | No between group differences for improving GMFM sitting sub scale or muscle activity on EMG. | No | |
15a | Ketelaar 200114 | RCT 2 groups 1 = Functional training 2 = NDT & Vojta Immediate & long-term (6 & 12mo) effect | 55 | CP 2–7 y Mild–Moderate Spastic [hemiplegia, diplegia, quadriplegia] | Functional Training Passive: nil Active: child generated movement solutions to reach goals, repetitive task-specific practice NDT Passive: normalized movement, facilitation, inhibition abnormal movement Active: nil | GMFM-88 standing & walking running & jumping dimensions [mobility function] PEDI [motor function] | 26 h both groups [intensity 1 h, frequency 1/wk, duration 26 wk] | Measures completed post randomization | Improved functional skills on the PEDI favoring Functional Training group No between group differences for gross motor skills on GMFM dimensions | No | |
16a | Ko 202049 | RCT 2 groups 1 = Group-based task -oriented training 2 = NDT Immediate effect | 18 | CP 4–7.5 y GMFCS I-III Spastic [unilateral & bilateral] | Group Task-Oriented Training Passive: nil Active: functional child goal-directed, activity interventions based on motor learning, feedback on performance. NDT Passive: unclear description: normalization of quality of movement, in line with NDT Active: unclear description, no active components described | GMFM-88 [gross motor function] BOT-2 manual dexterity subscale [fine motor function] PEDI [self-care, mobility] | 16 h both groups [intensity 1 h, frequency 2/wk, duration 8 wk] | Lack of concealed group allocation Control of other school and community activities not factored into intensity Between group differences unable to be measured long-term as no follow up of comparator group | Significant improvement in GMFM-88 (standing and walking/running/jumping dimension) Improved manual dexterity on BOT-2 and social function on PEDI favoring task-oriented training group No between group differences on any outcome measure | No | |
17a,b | Palmer 198841 | RCT 2 groups 1 = Infant stimulation 2 = NDT Immediate effect | 48 | CP 12–19 mo Mild–Severe Spastic [diplegia] | Infant Stimulation Passive: nil Active: active practice of motor, cognitive and language tasks using the Learning Games curriculum NDT Passive: improvement of righting & equilibrium reactions Active: nil | BMS [motor function] Bayley Scales Mental quotient [cognition] Vineland Social Maturity Scale [social development] | 12h infant stimulation [intensity 1 h, frequency 0.5/wk, duration 26 wk] 20 h NDT [intensity 1 h, frequency 5/wk, duration until sitting achieved] | NDT not well described Higher dose favoring NDT | Improved motor skills, walking and cognitive development favoring infant stimulation, despite NDT being offered at a higher dose No between group difference for social development | No | |
18 | Sah 201961 | RCT 2 groups 1 = Task oriented NDT (TOA-NDT) 2 = conventional physiotherapy Immediate effect | 44 | CP 7–15 y GMFCS II-III Spastic [diplegia] | Task-Oriented Activities Based on NDT (TOA-NDT) Passive: facilitation for optimal trunk alignment Active: trunk activation in multiple planes in sitting and standing using hands-on facilitation. Reaching during activity (popping bubbles, reach for balls, transferring) Conventional Physiotherapy Passive: passive stretch and range of movement of lower limbs Active: pegboard reaching task, standing on balance board, ball throwing | GMFM-88 [gross motor function] Postural Assessment Scale [postural control] Pediatric Balance Scale [dynamic balance ability] Trunk Impairment Scale [sitting balance function] | 36 h TOA-NDT [intensity 1h, frequency 6/wk, duration 6 wk] 36 h Conventional Physio therapy [intensity 1 h, frequency 6/wk, duration 6 wk] | Nonblinded assessment of outcomes | Improvement in gross motor function and dynamic balance skills favoring TOA-NDT group over passive stretch group No between group differences for postural control and dynamic sitting balance | Yes | |
19a | Salem 200940 | RCT 2 groups 1 = Task-orientated training 2 = NDT Immediate effect | 10 | CP 4–12 y GMFCS I-III Spastic [diplegia, quadriplegia] | Task-Oriented Training Passive: nil Active: task-orientated strength training, practice of functional tasks NDT Passive: facilitation, normalization of movement Active: nil | GMFM-88 standing and walking dimensions [mobility] TUG [mobility] | 10 h [intensity 1h, frequency 2/wk, duration 5 wk] | No calculation to justify small sample size | Improved gross motor skills in standing and walking on the GMFM favoring the task-orientated training Improved mobility speed on TUG favoring the task-orientated training group | No | |
NDT vs Body Function & Structures-Based Approaches | |||||||||||
20a | Avcil 202046 | RCT 2 groups 1 = Video game-based therapy (VGBT) 2 = NDT immediate effect | 30 | CP 10 y (mean age) GMFCS I-IV Spastic [hemiplegia, diplegia] Dyskinesia | VGBT Passive: tone regulation, sensory support Active: simulated sports (tennis and boxing), progressive repetitive wrist and hand games, grip development games, feedback via video hand controller NDT Passive: tone regulation, sensory support, facilitation for normalized movement Active: dressing, eating, increased complexity of activities | Minnesota Manual Dexterity Test (MMDT) [manual dexterity] Childhood Health Assessment Questionnaire [functional ability] Duruoz Hand Index [fine motor function] Dynamometry [grip and pinch strength] | 24 h both groups [intensity 1 hr, frequency 3/wk, duration 8 wk] | Motor severity different between groups at baseline Unable to assess tone outcomes as low numbers of infants displayed spasticity | Improved manual dexterity favoring VGBT group for hemiplegia, improved grip strength in both groups | No | |
21a | Bar-Haim 200636 | RCT 2 groups 1 = Adeli Suit 2 = NDT Immediate & long-term (9 mo) effect | 24 | CP 5–12 y GMFCS II-IV Spastic [diplegia, triplegia, quadriplegia] Ataxic Mixed | Adeli Suit Passive: massage, stretching, suit wearing Active: walking on varied terrains, sit-to-stand, ball play, trampoline jumping, stair-climbing, ladder-climbing NDT Passive: stretching, normalizing tone, facilitation of movement Active: walking, sit-to-stand | GMFM-66 [gross motor function] Mechanical efficiency during stair climbing | 40 h both groups [intensity 2 h, frequency 5×/wk, duration 4 wk] | Short duration intervention | Improved mechanical efficiency during stair climbing favoring the suit group No difference between groups for gross motor function | No | |
22a | Batra 201559 | RCT 2 groups 1 = Neuro-facilitation of Developmental Reaction (NFDR) 2 = NDT Immediate effect | 30 | CP IQ ≥ 55 4–7 y Mild–Moderate Spastic [topography unclear] | NFDR Passive: preparation for movement, facilitation, vestibular input, normalization of tone and reflexes Active: perturbation to elicit adaptive postural reactions, training motor control NDT Passive: positioning, handling, stretching, inhibition and facilitation techniques, weight-bearing Active: nil | GMFM-88[gross motor function] Modified Ashworth Scale [muscle tone, spasticity] Primitive Reflex Intensity Grading Score [reflex status] | 24 h both groups [intensity 40 min, frequency 3×/wk, duration 12 wk] | Interventions have similar characteristics No calculation to justify small sample size Report on change in GMFCS levels favoring NFDR which seems unfeasible | Reduced spasticity in select muscle groups and improved gross motor function and GMFCS levels favoring NFDR No change in reflex status between groups | No | |
23a,b | Batra 201258 | RCT 2 groups 1 = NFDR 2 = NDT Immediate effect | 30 | CP 0.5–2 y Mild–Moderate Spastic [topography unclear] | NFDR Passive: preparation for movement, facilitation, vestibular input Active: perturbation to elicit postural reactions NDT Passive: positioning, handling, stretching, weight-bearing Active: nil | GMFM-88[gross motor function] Modified Ashworth Scale [muscle tone, spasticity] Primitive Reflex Intensity Grading Score [reflex status] | 24 h both groups [intensity 40 min, frequency 3×/wk, duration 12 wk] | Small sample size Interventions are similar in many elements | Reduced spasticity in select muscle groups and improved gross motor function favoring NFDR | No | |
24a | Nam 201747 | RCT 2 groups 1 = Dynamic balance training 2 = NDT Immediate effect | 15 | CP 14 y (mean age) GMFCS I-III Spastic [diplegia] | Dynamic Balance Passive: nil Active: active balance on a balance trainer device, where the child’s load forces to actively maintain balance were recorded NDT Passive: unclear description Active: unclear description | Muscle thickness (on ultrasound) [proxy for muscle strength] | 9 h [intensity 30 min, frequency 3×/wk, duration 6 wk] | No measurement of the functional implications of this treatment | Between group difference of muscle thickness favoring dynamic balance training | No | |
25b | Scherzer 197660 | RCT 2 groups 1 = Passive stretching 2 = NDT Immediate effect | 24 | CP, high risk CP <18 mo Mild–Severe Spastic Athetoid [dyskinetic] Ataxic Mixed | Passive Stretch Passive: passive range of motion Active: nil NDT Passive: positioning to inhibit abnormal reflexes, facilitation, parents trained in techniques Active: movement to inhibit abnormal reflexes, stimulation of movement | Motor Development Evaluation Form [motor function] Social Maturation questionnaire [social development] Home management questionnaire [self-care] | Unable to calculate dose [intensity: not listed, frequency 2×/wk, duration: mean 12.5 mo] | Underpowered sample size Non standardized outcome measures Between group difference not measured | Improvement in motor status and social maturation after NDT | Yes | |
26a | Shamsoddini 201065 | RCT 2 groups 1 = Sensory integration (SI) 2 = NDT Immediate effect | 22 | CP 2–6 y Severity not listed Spastic [diplegia, quadriplegia] | NDT Passive: stretching, reducing spasticity, facilitation, normalized movement Active: nil SI Passive: stretching, reducing spasticity, facilitation, normalized movement Active: visual motor coordination, ocular pursuit activities, pegboard activities, turning left & right | GMFM-88 [gross motor function] | 36–54 h [intensity 1–1.5 h, frequency 3×/wk, duration 12 wk] | Possible reporting error No calculation to justify small sample size | Improved lying, sitting, crawling motor skills on GMFM-88 favoring SI | No | |
NDT vs Environmental-Based Approaches | |||||||||||
27b | Hanzlik 198962 | RCT 2 groups 1 = Parent coaching 2 = NDT Immediate effect | 20 | CP & developmental delay 1–2 y Mild–Severe Spastic [hemiplegia, diplegia, quadriplegia] | Parent Coaching Passive: adaptive seating for infant Active: coaching in play responsivity, reduced physical contact which was converted to face-to-face contact + communication NDT Passive: facilitation, normalized tone, normalized movement Active: nil | Modified Milani-Comparetti and Gidoni Scale of Gross Motor Development [gross motor function] Bayley Scales of Mental Development [cognition] Maternal Observation Interview [behavioral styles] Hollingshead Four-Factor Index of Social Position [socioeconomic status] | 1 h [intensity: 1 h coaching or NDT + home practice dose unspecified] | Brief descriptions of the intervention Low dose both groups | Improved infant responsiveness favoring parent coaching group No between group differences for independent play | No | |
28b | Girolami 199463 | RCT 3 groups 1 = NDT 2 = Nonspecific handling 3 = Term controls (no therapy) Immediate effect | 27 | Preterm infants at risk for CP, 34 wk GA 0–1 y Term-born controls Severity & topography not clear | Nonspecific Handling Passive: positioning without NDT handling Active: nil NDT Passive: handling, facilitation Active: active postures during handling | Neonatal Behavioral Assessment Scale (NBAS) motor cluster [motor function] Supplemental Motor Test [motor control] | 5 h [intensity 15 min, frequency 14/wk, duration 1–2 wk] | High attrition rates Small sample size Risk for CP not clearly defined, i.e. these preterm infants may have been on a trajectory to a normal outcome and thus not needed treatment | Improved motor performance on the NBAS favoring NDT No between group difference for tone, behavioral state, reflexes & regulation | Partially | |
NDT Higher Dose vs NDT Lower Dose | |||||||||||
29 | Bower 199642 | RCT 4 groups 1 = Lower dose NDT + aims 2 = Higher dose NDT + aims 3 = Lower dose NDT + goals 4 = Higher dose NDT + goals Immediate effect | 44 | CP 3–11 y Moderate– Severe Spastic [quadriplegia] | NDT Passive: unclear description Active: unclear description | GMFM-88 [gross motor function] | 2 h mean lower dose (aims + goals group) [duration 2 wk] 9 h mean higher dose (aims + goals group) [duration 2 wk] | Low dose in both groups within the context of neuroplasticity | No between group differences for lower versus higher dose group for gross motor function Improved gross motor skills on the GMFM favoring goals over aims | No | |
30 | Bower 200143 | RCT 4 groups 1 = Lower dose NDT + aims 2 = Higher dose NDT + aims 3 = Lower dose NDT + goals 4 = Higher dose NDT + goals Immediate effect | 56 | CP 3–12 y GMFCS III-V Spastic [bilateral] | NDT Passive: stretching, handling, positioning, equipment, orthoses, casting Active: muscle strengthening, active movement, gross motor skills training | GMFM-88 [gross motor function] Gross Motor Performance Measure (GMPM) [gross motor performance] MPOC-20 [parent perception of care giving] | 36 h median lower dose [intensity 1 h, frequency 0.5/wk, duration 72 wk] 112 h median higher dose [intensity 5 h, frequency 1/wk, duration 26 wk + intensity 1 h, frequency 0.5×/wk, duration 46 wk] | These doses would be considered to be in the therapeutic range but are over a long duration (18 mo) Multiple treating therapists | No between group differences for aims versus goals or lower dose v higher dose for gross motor skills on GMFM or GMPM | No | |
31a | Law 199144 | RCT 4 groups, 2 groups relevant to dose question 1 = Lower dose (regular NDT) 2 = Higher dose (intensive NDT) Immediate & long term (3 mo) effect | 36 | CP 1.5–8 y Severity not listed Spastic [hemiplegia, quadriplegia] | NDT Passive: weight-bearing, facilitation Active: reaching & grasping, bilateral co-ordination | Peabody fine motor scales [fine motor function] QUEST [quality of upper extremity movement] | 39 h lower dose NDT [intensity 45 min, frequency 1/wk + home program 30 min 3×/wk, duration 26 wk] 130 h higher dose NDT [Intensity 45min Frequency 2/wk + home program 30min 7×/wk Duration 26wk] | Small sample size leading to underpowered study Variation in dose within groups | No between group difference for fine motor function on PDMS or quality of movement on QUEST | No | |
32b | Mayo 199164 | RCT 2 groups 1 = Lower dose NDT 2 = Higher dose NDT Immediate effect | 29 | CP 0–1.5 y Moderate– Severe Spastic [hemiplegia, diplegia, quadriplegia] | NDT Passive: unclear description Active: unclear description | Aggregate of 7 instruments: (reflex activity, postural reactions, Wolanski Gross Motor Evaluation, [gross motor function], fine motor, Bayley mental scale, Abnormal movement scale, activities of daily living) | 6 h median lower dose [intensity 1 h, frequency 1/mo, duration 26 wk + unspecified intensity for home program] 26 h median higher dose [intensity 1 h, frequency 1/wk, duration 26 wk + unspecified intensity for home program] | Low dose in both groups within the context of neuroplasticity High rate of no CP by end of study (31%) Reported aggregate score with 7 instruments meaning score could artificially rise if the child made improvements on a test in which they had no impairments | Improved skills on aggregate of 7 instruments favoring higher dose NDT | Yes | |
33a | Tsorlakis 20044 | RCT 2 groups 1 = Lower dose NDT 2 = Higher dose NDT Immediate effect | 34 | CP 3–14 y GMFCS I-III Spastic [hemiplegia, diplegia, quadriplegia] | NDT Passive: unclear description Active: unclear description Based on Bobath principles 1994–2001 era, suggesting it probably included: handling, facilitation, normalization of movement | GMFM-66 [gross motor function] | 32 h median lower dose [intensity 1 h, frequency 2/mo, duration 16 wk] 80 h median higher dose [intensity 1 h, frequency 5/wk, duration 16 wk] | Unclear description of intervention Underpowered study (did not meet calculated sample size) | Improved gross motor skills on the GMFM favoring higher dose NDT. Results were larger in younger children | Yes | |
34b | Weindling 199650 | RCT 2 groups 1 = Lower dose NDT (delayed physiotherapy) 1 = Higher dose NDT (early physiotherapy) Immediate & long-term (at age 30 mo) effect | 110 | Infants at risk for CP on neuroimaging, included preterm and term born infants CP (n = 45) 0–1 y Severity not clear Spastic [hemiplegia, diplegia, quadriplegia] | NDT Passive: handling, positioning, passive limb movement Active: holding feeder cup | Griffiths Developmental Quotient [general development] included analysis of sub scales: Locomotor Personal Social Performance Hearing– Speech Eye–Hand Mental Range | 16 h lower dose [intensity not listed, frequency 1/wk, duration 16 wk] 35–52 h higher dose [intensity: not listed, frequency 1/wk, duration 35–52 wk] Doses estimated on 1 h/session | Dose difficult to calculate as intensity not listed No stratification for motor severity, leading to nonbaseline equivalence for severity favoring higher dose group Griffiths locomotor scale not valid for severe motor impairment Only 50% of infants had CP outcome | No between group difference at 12 or 30 mo for motor development or total developmental quotient on Griffiths | No | |
35a,b | Weindling 200751 | RCT 2 groups 1 = Lower dose NDT (standard care physiotherapy) 2 = Higher dose NDT (NDT + NDT therapy given by physiotherapy assistant Immediate & long-term (6 & 12 mo post intervention) effect | 76 | CP <4 y Severity not listed Spastic [hemiplegia, diplegia, quadriplegia] | NDT Passive: normalization of posture and movements, movement facilitation. Active: nil | GMFM [gross motor function] Griffiths [general development] Vineland [adaptive functioning] Various parent, home ecology measures | 32 h lower dose (estimate) [intensity & frequency not standardized] 60 h higher dose = 34 h standard NDT physio [intensity & frequency not standardized] + 26 h physio assistant [intensity 1 h, intensity 1/wk, duration 6 mo] | Dose not able to be estimated (estimate from number of contacts) | No between group difference between higher and lower intensity NDT | No |
AHA, Assisting Hand Assessment; BOT-2, Bruininks-Oseretsky Test of Motor Proficiency second Edition; CNS, central nervous system; COPM, Canadian Occupational Performance Measure; CP, cerebral palsy; BMS, Bayley Motor Development Scale; CIMT, constraint-induced movement therapy; DDST, Denver Developmental Screening Test; EEG, EEG; EMG, Electromyography; HABIT-ILE, Hand and Arm Bimanual Intensive Therapy Including Lower Extremity; GA, gestational age; GMFCS, Gross Motor Function Classification System; GMFM, Gross Motor Function Measure; GMPM, Gross Motor Performance Measure; IQ, IQ; MiniMACS, Mini Manual Ability Classification System; MPOC-20, Measure of Processes of Care; MMDT, Minnesota Manual Dexterity Test; NBAS, Neonatal Behavioral Assessment Scale; NICU, NICU; NDT, neurodevelopmental therapy; NDS, neurodevelopmental score; NFDR, Neurofacilitation of Developmental Reaction; OT, occupational therapy; PDMS, Peabody Developmental Motor Scales; PEDI, Pediatric Evaluation of Disability Inventory; QUEST, Quality of Upper Extremity Skills Test; RCT, randomized controlled trial; SI, sensory integration; TOA-NDT Task oriented NDT; TUG, Timed Up and Go; VGBT, video game-based therapy; WCISD, Wayne County Intermediate School District’s Gross Motor Evaluation.
Met inclusion criteria for meta-analysis.
Considered infant population.
Synthesis of Results
NDT Versus Control
We identified 9 studies (in 10 publications)33–35,45,52–57 comprising 418 participants (Table 1) that compared NDT against a control. Controls consisted of no therapy (6 studies in 7 publications)33,34,45,53,55–57 or passive movement approaches with no child self-generated movements (n = 3).35,52,54 In total, 6 publications did not meet inclusion for meta-analysis for the following reasons: (1) data not extractable (n = 4),53,55–57 (2) no common outcome (n = 1),45 and (3) outcome timeframe not comparable (n = 1).33 Four publications34,35,52,54 (n = 138 participants), 2 of which had high risk of bias,52,54 met inclusion criteria for meta-analysis for motor function outcome (Fig 2A). No difference was found between NDT and control for motor function with a pooled effect size of 0.13 (95% CI = −0.20 to 0.46), I2 = 0%.
NDT Versus Activity-Based Approaches
We identified 9 studies14,37–41,48,49,61 comprising 307 participants (Table 1) for NDT versus activity-based approaches. In total, 8 studies14,37–41,48,49 comprising 255 participants met inclusion for meta-analysis for motor function outcomes. A moderate pooled effect size of 0.76 (0.12 to 1.40), I2 = 80% was observed, favoring activity-based approaches for motor function (Fig 2B). One outlier61 was excluded from meta-analysis because the intervention was primarily activity-based but used facilitation techniques. A meta-analysis with this outlier included is available in Supplemental Fig 4A. On subanalysis to account for heterogeneity, when studies with norm-referenced outcome measures14,41,49 were excluded, both heterogeneity and pooled effect size decreased (0.42 [−0.08 to 0.93], I2 = 36%) favoring activity-based interventions (Supplemental Fig 4B).
Subanalysis of 2 studies37,39 (n = 38 participants) that tested upper limb interventions and were analyzed for upper limb motor outcomes revealed activity-based approaches improved upper limb motor function over NDT with a large, pooled effect of 0.83 (0.16 to 1.50) I2 = 0% (Supplemental Fig 4C). However, there was no difference of effect for lower limb interventions for lower limb motor function outcomes from 4 studies14,38–40 (n = 165 participants, outlier61 excluded), with a pooled effect of 0.68 (−0.18 to 1.54), I2 = 82% (Supplemental Fig 4D). No change in results were seen when norm-referenced outcome measures14,39 were excluded accounting for heterogeneity in lower limb motor function (0.03 [−0.39 to 0.46], I2 = 0%) (Supplemental Fig 4E). All studies were rated low risk of bias or some concerns, except for the outlier61 which was assessed as high risk of bias.
NDT Versus Body Function and Structures-Based Approaches
We identified 7 studies36,46,47,58–60,65 with 175 participants (Table 1) that tested NDT versus body function and structures-based approaches. Only 1 study60 did not meet inclusion criteria for any meta-analyses in this comparator because data were not extractable. Motor function was the most common outcome reported. In total, 5 studies36,46,58,59,65 met inclusion for a motor function outcome meta-analysis, with a moderate pooled effect size of 0.77 (0.19 to 1.35), I2 = 61% favoring body function and structures approaches (Fig 2C). Other outcomes were muscle strength, muscle tone, and primitive reflex status. In total, 2 studies were combined for strength outcomes46,47 with no effect found (0.02 [−0.56 to 0.61]) (Supplemental Fig 4F). In addition, n = 2 studies,58,59 which tested the neurofacilitation of developmental reaction (NFDR) approach, were combined and analyzed for effect on muscle tone and primitive reflex status. NFDR was favored for improving muscle tone outcomes (0.97 [0.43 to 1.51]) (Supplemental Fig 4G); however, no effect was found for primitive reflex status (0.35 [−0.16 to 0.86]) (Supplemental Fig 4H). Notably, both these studies58,59 were assessed as high risk of bias.
NDT Versus Environmental-Based Approaches
We identified 2 studies62,63 comprising 47 participants who were all infants that compared NDT to environmental-based approaches. One study63 partially favored NDT over a nonspecific handling intervention and 1 study62 favored a parent coaching model over NDT. Comparison interventions of studies, parent coaching, and passive handling were not similar enough for meaningful meta-analysis. Additionally, both studies had a high risk of bias.
NDT Higher Dose Versus Lower Dose
We identified 7 studies4,42–44,50,51,64 with 385 participants that compared 2 doses of NDT. In total, 3 studies4,44,51 met inclusion for meta-analysis for motor function outcomes. Average low dose was 35 (standard deviation = 3) hours versus 90 (36) hours high dose. Reasons for exclusion from meta-analysis included (1) data not extractable (n = 2 studies)43,50 and (2) dose <30 hours threshold (n = 2).42,64 No difference between higher and lower dose NDT on motor function was found with an effect size of 0.32 (−0.11 to 0.75), I2 = 30% (Fig 2D). Interpretation of all meta-analyses did not change using a fixed effects model.
NDT in Infants
Across all included studies, we identified 1133,34,41,50,51,57,58,60,62–64 publications that enrolled infant participants <2 years, including 2 articles,34 written about the same cohort. These infant studies comprised 578 infants, of which 259 (44.8%) had confirmed CP. Studies were spread across all comparators including NDT versus control (n = 3),33,34,57 NDT versus activity-based approaches (n = 1),41 NDT versus body function and structures-based approaches (n = 2),58,60 NDT versus environment-based approaches (n = 2),62,63 and NDT lower versus higher dose (n = 3).50,51,64 In total, 8 studies33,34,41,51,58,62–64 had extractable standardized mean difference data; however, no 2 studies were sufficiently homogenous in terms of participants, interventions, outcomes, or outcome measures to conduct a meaningful meta-analysis. Of 11 infant studies, 2 of 11 (18%) favored NDT, 1 of 11 (9%) partially favored NDT, and 7 of 11 (64%) did not favor NDT (Table 1). When studies with some concerns or a high risk of bias were excluded, only 1 study remained41 that revealed infant stimulation, and an activity-based approach improved motor skills over NDT with a large effect size (2.62 [1.83 to 3.41]) (Fig 2B).
Reporting Biases
On RoB-2 only 5 of 35 publications52,53,57,62,63 had high risk and 5 of 3514,45,48,49,60 had some concerns of reporting bias (assessed on Domain 5 of RoB-2), meaning that, overall, there was a low risk of reporting bias among the included studies. A funnel plot of each meta-analysis was visually inspected, with no asymmetry detected for any comparator, indicating a low risk for reporting bias.
Certainty of Evidence
Overall, based on GRADE methodology, the body of evidence was rated as moderate-quality. Recommendations for the use of NDT for children and infants with CP are (1) strong recommendation for the use of activity-based approaches in preference to NDT for improving motor function (with decisions informed by evidence certainty, benefits versus lost opportunity, family and clinician preferences, cost-effectiveness) and (2) strong recommendation against the use of NDT at any dose for improving motor function (with decisions informed by evidence certainty, benefit versus lost opportunity, cost-effectiveness, parent preference, feasibility, and family burden). Evidence and reasoning for the strength of recommendations are detailed in the Supplemental Material 1. The effect size and comparative effectiveness of each meta-analysis are depicted in a bubble chart traffic map using GRADE32 recommendations and the Evidence Alert System22 (Fig 3).
Discussion
Our primary objective was to determine the efficacy of NDT on any outcome in children and infants with CP or high risk for CP. We found 35 RCTs evaluating NDT efficacy, which is a larger body of evidence than for most topics in CP rehabilitation. Despite the moderate quality of the evidence, the claim that insufficient evidence exists to judge the efficacy of NDT can be seriously challenged. We found no difference in effect between NDT and control or between different doses of NDT. In addition, activity-based and body function and structures-based approaches improved motor function over NDT with a moderate effect. Findings reveal top-down interventions are superior for improving motor function compared with bottom-up interventions.
We have made strong recommendations for the use of activity-based interventions in preference to NDT and against the use of NDT at any dose to improve motor outcomes in infants and children with CP. The certainty of evidence (moderate quality) in combination with the effect size of interventions, the value people place on effective motor interventions, costs, impact on health equity, acceptability, and feasibility of NDT versus alternative effective interventions using the GRADE methodological approach32 were all considered.
It is worth discussing the exclusion of the outlier study61 from the NDT versus activity-based meta-analysis. In this study, the NDT intervention consisted of facilitation handling in combination with a range of activity-based elements, including trunk activation, reaching during standing or sitting activities. The comparison intervention consisted primarily of passive stretching with some active tasks therefore, not truly an activity-based approach that could be pooled with other studies. Results from the outlier study61 suggest a child-active approach is the effective element in neurorehabilitation.
Overall body functions interventions improved motor function over NDT, but the effect size was influenced by the studies with a high risk of bias, meaning this result should be interpreted with caution. Studies that compared NDT with other body function and structures-based approaches for muscle strength46,47 used strength measures taken from single muscle groups; therefore results are unlikely to have functional implications. The 2 studies that compared NDT with body function and structures-based approaches for muscle tone outcomes58,59 tested NDT versus the NFDR approach. Both studies had a high risk of bias based on invalid use of the Modified Ashworth Scale;66 therefore the result that NFDR is superior to NDT for improving muscle tone should be interpreted with caution. The same 2 studies58,59 revealed no difference between NDT and NFDR on primitive reflex status. This is not surprising given it is scientifically unlikely that distal manual interventions will impact central nervous system reflexes.
We only found 2 studies62,63 that tested NDT versus environmental approaches. The low methodological quality of these studies meant no meaningful results could be extrapolated in this review.23,62,63 However, another systematic review revealed environmental enrichment improves motor function in infants with CP with a small effect size (0.39 [0.05 to 0.72]).67 Other effective interventions (ie, constraint-induced movement therapy)68 also use enriched environments to induce repetition, practice, and learning. Because home environments are typically more enriching, we recommend practice in a child’s real-life environment.69
A previous systematic review from 200119 found NDT is not more effective in a higher than lower dose and our review support these results. One study,4 with a low risk of bias, is highly cited when advocating the effectiveness of NDT for improving motor function. However, on close examination, the CIs for the effect size (0.25 [−0.42 to 0.93]) cross the line of no effect suggesting no genuine statistical difference between doses.
Studies including infants <2 years revealed a range of outcomes and interventions across all comparators. Most infant studies did not favor NDT. Palmer and colleagues’ publication41 was the only infant study assessed as low risk of bias to reveal a clear effect that infant stimulation, an activity-based approach, improved motor outcomes over NDT. The Palmer study reflects an emerging trend in CP early interventions in which early, activity-based, top-down approaches are more effective than bottom-up approaches in improving motor function.23,70,71 In addition, findings are consistent with results in older children with CP outlined in this systematic review. Intervention efficacy for infants is a well-known gap in the CP literature. Until recently, early detection of CP was not routine, leading to a lack of infant intervention trials. Now, with guidelines for accurately identifying infants with CP,24 more studies testing interventions in infants with CP are underway.
Historically, it was argued that the evidence quality was too poor and evidence volume too small to adequately test NDT. The quality of studies varied in this review; 11 of 35 studies had a low risk of bias, and the overall body of evidence was rated moderate-quality by using GRADE.32 However, we did find 35 RCTs with 1332 participants with outcomes principally pointing in the same direction. In addition, results in this review mirror recommendations for children72 and adults73 after stroke, which, although a different population, have similar mechanisms of action for neurorehabilitation.
In this review, ineffective interventions for motor function had the following common features: facilitation, handling and positioning to normalize or minimize atypical motor behavior (movement), tone and reflexes/reactions, passive stretching, sensory support, and vestibular input. In contrast, effective interventions had the following common features: learning through active self-generated movement, progressive, repetitive, and varied specific task practice, performance feedback, real-life meaningful goals, and child problem-solving, all of which are based on neuroplasticity principles.74,75
Limitations
Most studies were published before Consolidated Standards of Reporting Trials-compliant RCT76 reporting. The NDT versus control comparator included studies primarily from the 1970s and 1980s. It is no longer ethical to provide no therapy or passive comparison interventions. Studies were screened for “Bobath,” “NDT,” and “Neurodevelopmental therapy” or “treatment” search terms in titles and abstracts. It is likely studies that used NDT but described it as “physiotherapy,” “occupational therapy,” or “traditional therapy” in the full text may have been missed. However, given the volume of literature found and the use of hand searching, this is unlikely to have influenced our findings. Heterogeneity of the NDT versus activity-based approaches meta-analysis was considerable but accounted for by diverse outcome measures on subanalysis. Heterogeneity of infant studies is a limitation of the evidence; however, with likely effective interventions in this population,71,77 a strong recommendation against the use of NDT in infants was made. Despite some studies with small sample sizes and dated methods being a limitation, it is still striking that most studies did not favor NDT. Lastly, excluding studies with <30 hours dose for the dosage comparator could be a limitation because there are some effective interventions with <30 hours dosage.
Implications for Practice, Policy, and Future Research
Results from this review support the deimplementation of NDT in clinical practice. Deimplementation requires evidence-based, multifaceted, and context-specific strategies,78 which include policy changes, restructuring funding, and financing training for effective alternatives to NDT.79 Multiple alternatives for NDT exist;23 for example, task-specific training,80 goal-directed training,80 treadmill training,81 constraint-induced movement therapy,82 action observation,30 and bimanual therapy.82,84–86 Clinical education in these effective alternatives is required because Bobath or NDT training is considered the best rehabilitation training in some countries.
Conclusions
We found activity-based interventions are more effective than NDT and no difference between higher and lower dose NDT, nor between NDT and control for improving motor function in CP. We give strong recommendations for the use of activity-based interventions in preference to NDT and against the use of NDT at any dose to improve motor function in CP. Deimplementation of NDT in clinical practice is warranted and will provide the best outcomes for children with CP.
Acknowledgments
We acknowledge Callum McEwan for his contribution to data extraction.
Ms te Velde conceptualized and designed the study, completed searches, extracted data, conducted analyses, prepared data visualization, and drafted and revised the manuscript; Dr Morgan conceptualized and designed the study, extracted data, oversaw analyses, and drafted, critically reviewed, and revised the manuscript; Dr Finch-Edmondson supported searching, extracted data, prepared data visualization, and critically reviewed and revised the manuscript; Ms McNamara, Dr McNamara, and Ms Stanton extracted data and critically reviewed and revised the manuscript; Dr Paton extracted data, prepared data visualization, critically reviewed and revised the manuscript; Ms Webb supported formal analysis and critically reviewed and revised the manuscript; Prof. Badawi critically reviewed and revised the manuscript; Prof. Novak conceptualized and designed the study, extracted data, oversaw analyses, prepared data visualization, drafted, critically reviewed and revised the manuscript; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
FUNDING: No external funding.
CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no potential conflicts of interest to disclose.
Comments
Contemporary Neuro-developmental Treatment Practice Model and Definition Raise Serious Challenges to the Call for De-implementation of NDT
Key concepts of contemporary NDT practice include:
1. A holistic and interdisciplinary view of practice informed by current evidence.
2. Use of clinical reasoning strategies informed by ongoing analysis of interactions within and between domains of the ICF model, as well as contextual facilitators and barriers.
3. Outcomes based on increasing functional activity and participation in accordance with patient/family goals and preferences
4. Incorporation of patient-specific therapeutic handling within the context of functional tasks and the environment. It is based on movement analysis and consists of an active reciprocal interaction between the child and therapist.
Our literature review revealed multiple recent, peer-reviewed publications, which investigated NDT intervention efficacy incorporating the contemporary NDT Practice Model and definition.2-5 While not all publications were traditional RCTs, patient populations, interventions and dosing were well defined and consistent across groups. Appropriate outcomes measures were used across multiple domains and ICF levels. Analysis of this body of evidence provides support for the continued use of contemporary NDT interventions for children living with CP
For example, Sah,et al’s 2019 RCT compared contemporary NDT intervention to conventional physical therapy in 54 children with spastic diplegic CP.3 Outcomes measures included the Gross Motor Function Measure-88, the Postural Assessment Scale, the Pediatric Balance Scale, and the Trunk Impairment Scale. After a 6-week intervention, results supported contemporary NDT over conventional PT in improving trunk control, balance, and gross motor function. Tsorlakis et al4 and Evans-Rogers5 examined dosing of contemporary NDT intervention and reported improved gross motor function with increased NDT dose.
Research of contemporary NDT practice does not support the de-implementation of NDT as a clinical practice model. We recommend continued research using the contemporary NDT Practice Model and definition, with appropriate selection of subjects and outcomes measures.
References
1. Bierman J, Franjoine MR, Hazzard C, Howle J, Stamer M. Neuro-Developmental Treatment: A Guide to Clinical Practice. Thieime, 2016
2. Holland H, Blazek K, Haynes MP, Dallman A. Improving postural symmetry: The effectiveness of the CATCH (Combined Approach to Treatment for Children with Hemiplegia) protocol. J pediatr Rehabil Med. 2019;12:139-149 DOI: 10.3233/PRM-180550
3. Sah AK, Balaji GK, Agrahara S. Effects of Task-oriented Activities Based on Neurodevelopmental Therapy Principles on Trunk Control, Balance, and Gross Motor Function in Children with Spastic Diplegic Cerebral Palsy: A Single-blinded Randomized Clinical Trial. J Pediatr Neurosci. 2019;14(3):120-126. DOI:10.4103/jpn.JPN_35_19
4. Tsorlakis N, Evaggelinou C, Grouios G, Tsorbatzoudis C. Effect of intensive neurodevelopmental treatment in gross motor function of children with cerebral palsy. Dev Med Child Neurol. 2004;46(11):740-745. DOI: 10.1017/s0012162204001276
5. Evans-Rogers DL, Sweeney JK, Holden-Huchton P, Mullens PA. Short-term, intensive neurodevelopmental treatment program experiences of parents and their children with disabilities. Pediatr Phys Ther. 2015;27(1):61-71. DOI:10.1097/PEP.0000000000000110.
Bobath is a school of thought not a treatment.
A treatment is a tool for therapists’ toolbox, and a clinical approach is a way of viewing a condition to decide how and when to use which tool for each individual living with cerebral palsy, taking account of their particular presentation and context. This approach has much more in common with concep-tual frameworks like the International Classification of Functioning, Disability and Health suggested by the World Health Organization [3] than it does with an individual treatment. The advantage of which means it can be used by all disciplines and therefore facilitates collaborative thinking.
Cerebral palsy is a complex health condition and as such management requires significant clinical reasoning skills [4] that can be used across all levels and all classifications. As commented by Mayston, dis-implementation of Bobath risks losing vital clinical reasoning skills and clinical reason-ing training for therapists. Clinical reasoning is a fundamental part of every therapist’s practice. Clini-cal reasoning proficiency is required to select the most appropriate treatment, and to be effective, all of which rely on many practitioner attributes gained through both training and experience. Bo-bath therapists often expand their toolbox by integrating new information and treatments into their practice in the same way a plumber may add the latest drill, or a surgeon apply a new procedure. Using new information and adding new tools into a therapist’s toolbox does not prevent them from being a Bobath therapist, but it means they are being a reflective and proactive therapist - applying clinical reasoning skills and developing professional expertise. Keeping up to date is the duty of health professionals, although every professional population has a large range of abilities and experi-ence. A Bobath course is an introduction to a school of thought – to develop thinking therapists. Un-like treatments which have rules and criteria for guidance, a school of thought is open to interpreta-tion. Therefore, progress in practice is significantly dependent on the clinician and their environ-ment. This variation in practice extends to teaching, with differences observed across countries and outdated practice certainly exists. The Bobath Concept as a school of thought should be evaluated along with the effect of its courses on therapy practice, and this should be the direction of further studies.
References
1. te Velde A, Morgan C, Finch-Edmondson M, et al. Neurodevelopmental Therapy for Cerebral Palsy: A Meta-analysis.Pediatrics. 2022;149(6)e2021055061 2. Mayston, M. and Rosenbloom, L. (2014), Please proceed with caution. Dev Med Child Neurol, 56: 395-396. 3. https://www.who.int/standards/classifications/international-classification-of-functioning-disability-and-health last accessed June 16, 2022.4. Jackman M, Sakzewski L, Morgan C, Boyd RN, Brennan SE, Langdon K, Toovey RAM, Greaves S, Thorley M, Novak I. Interventions to improve physical function for children and young people with cerebral palsy: last accessed June 16, 2022. international clinical practice guideline. Dev Med Child Neurol 2022 ; 64: 536-549.
Beware of a Flawed Systematic Review with Broad Recommendations for Cerebral Palsy Treatment
Alfred L. Scherzer, MD, EdD, FAAP, Weill FAAP Medical College, USA
ABBREVIATIONS
CP-cerebral palsy
SR-systematic review
MA-meta-analysis
CG-clinical guideline
EBM -evidence-based evidence
AMSTAR- Assessing the Methodological Quality of Systematic Review
As a developmental pediatrician with extensive experience in the field of cerebral palsy (CP), I was troubled by the Velde et. al. article1 . It concluded with clinical guidelines based on faulty evidence review procedures and inappropriate guideline methods.
I sought the opinion of Charlene Butler, long active in the development and critical appraisal of the quality of SR and MA research evidence. She noted that research evidence about the conduct of research demonstrates that conclusions cannot be taken at face value, but must be critically appraised to establish their credibility 2. For example, a recent evaluation of the methodological quality of all SRs and MAs of interventions for CP published worldwide in the last 5 years using AMSTAR-2, the critical appraisal tool for systematic reviews3, found that 88% of those reviews revealed 1) critically low confidence ratings for their conclusions, and 2) neither restriction to randomized controlled trials, nor inclusion of MA, improved the confidence ratings. AMSTAR-2 defines “critically low rating” of a SR/MA to mean that it should not be relied on as an accurate and comprehensive summary of the evidence from the included primary studies. Butler’s appraisal of the quality of this SR/MA by Velde, et.al.,using AMSTAR-2, shows this paper is also deficient in multiple elements of robust review and synthesis procedures, and results in a critically low confidence rating.
In addition to poor quality procedures for synthesizing study evidence, Butler pointed out that the conclusions made were not an analysis of evidence but were clinical practice guidelines developed with an unvalidated tool called the Traffic Light ALERT System. It reduces treatment guidance using the analogy of obeying traffic. If coded green, “do it”; red, “don’t do it”; if yellow “maybe do it”.
What are pediatricians to do when they must act in the absence of certainty about efficacy from research studies? First, be guided by the broad tenet of evidence-based medicine (EBM), that evidence for decision-making includes the equal components of 1) research evidence, 2) patient’s preferences/actions, 3) clinical state and circumstances which are interpreted and mediated by 4) clinical expertise.4 Then, when an intervention decision has been reached, create evidence of efficacy of that intervention for that patient, while implementing the intervention. That involves developing and monitoring a care/study plan which will detail the intervention procedures, the desired outcomes, how and when outcomes will be measured, as well as recording of adherence. The plan will establish points in time to evaluate whether to continue with the intervention, modify it, or terminate it in order to pursue an alternative that may be more efficacious for this patient.
In sum, pediatricians need to be aware that, at present, neither this paper nor other current research provides definitive evidence in favor of any specific or exclusive physical therapy treatment for children with CP. Instead, decisions about therapy for these patients by all practitioners must be guided by the above broad principles of EBM.
Refrerences:
1. Velde A, Morgan C, Finch-Edmondson M, et al. Neurodevelopmental Therapy for Cerebral Palsy: A Meta-analysis. Pediatrics 2022;149(6):e2021055061
2. Kolaski K, Romeiser Logan L, Goss KD, Butler C. Quality appraisal of systematic reviews of interventions for children with cerebral palsy reveals critically low confidence. Devel Med Child Neurol 2021; 63 (11), 1316
3. Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. Brit Med J 2017; 358: j4008.
4. Wieten, S. Expertise in evidence-based medicine: a tale of three models. Philos
Ethics Humanit Med 2018; 13. https://doi.org/10.1186/s13010-018-0055-2
De-Implementation of NDT - an alternate Australian view
Rather than focusing on this study’s limitations and misrepresentation, ABNDTA will clarify its contemporary teaching approach in Australia since 2008.
ABNDTA embed Bobath/NDT training in the ICF and accompanying F-words in childhood disability frameworks [3] with thorough analysis of each ICF domain and their interaction and relationship. Therapists conduct in-depth task analysis of the components for successful functioning, including all domains that impact on the child's function including personal factors (sensory, motor, cognition), family factors and environmental context. Age and stage of the person reflects a lifespan approach. Current neuroscience curriculum is evidence based, including neuroplasticity and movement sciences – not neuro-maturational/ reflex-based theories of the last century.
Interventions are targeted and matched to the child's goals based on individual needs and context and evaluated using valid outcome measures. Training develops skills to understand which approach(s) to apply and when, to maximize outcomes – forming the basis of Bobath clinical reasoning practice. Clinical guidelines [4] are useful for novice clinicians as a starting point but cannot replace the clinical judgement and individualized application by a skilled therapist.
Opportunities for supported clinical practice in certification training facilitates knowledge translation through the direct and immediate use of knowledge-in-practice. The experience-based learning is shared by Physiotherapists, Occupational Therapists and Speech Pathologists - a model of transdisciplinary care. Targeted interventions relate to the whole child, rather than just upper limb or lower limb function. Communication is “everybody’s business” but is rarely featured in interventions or practice guidelines but, like play and occupation, are embedded in Bobath training. Knowledge of the range of interventions in clinical practice is not used eclectically to redefine the Bobath approach; rather, its clinical reasoning model ensures other specific timely interventions are implemented when appropriate.
Can de-implementation science be applied to a clinical reasoning model – challenging to do [5] and of potentially limited value, given that lack of post-graduate clinically based education is a barrier for therapist’s perceptions of competency in CP management
ABNDTA’s challenge is to define accurately what we do and promote research into the clinical reasoning model for clinical practice. Participation in research is welcome, including qualitative research so key stakeholders - children, families, and therapists navigating career pathways in developmental paediatrics- have a voice on what matters to them.
1. te Velde A, Morgan C, Finch-Edmondson M, et al. Neurodevelopmental Therapy for Cerebral Palsy: A Meta-analysis. Pediatrics. 2022;149(6):e2021055061. 2.Toovey R, Spittle AJ, Nicolaou A, McGinley JL, Harvey AR. Training two-wheel bike skills in children with cerebral palsy: a practice survey of therapists in Australia. Phys Occup Ther Pediatr. 2019;39(6):580–597; 3.Rosenbaum P & Gorter JW The ‘F-words’ in childhood disability: I swear this is how we should think! Child: Care Health Development.2012;38(4): 457-463. 4.Jackman M, Sakzewski,L, Morgan, C Boyd, RN et al (2021). Interventions to improve physical function for children and young people with cerebral palsy: international clinical practice guideline. Developmental Medicine and Child Neurology, 64 (5), 1-14. 5. Burton, C., Williams, L., Bucknall, T. et al. Understanding how and why de-implementation works in health and care: research protocol for a realist synthesis of evidence. Syst Rev 8, 194 (2019).
Deimplementation of Bobath and NDT: is it warranted?
It is clear that SRs can usefully provide a summary of the available evidence though they are not always robust forms of evidence [2] and are fraught with methodological challenges. A meta-analysis is similarly subject to limitations. A meta-analysis aims to look for consistency in treatment effects across a number of studies which are addressing the same question. This is a challenge for any study of Bobath or NDT. Not only are the two different, they contain many elements of intervention by a variety of disciplines, and will differ according to the age, GMFCS level of the child and their diagnosis [3]. It is therefore a challenge to directly compare the studies cited in the meta-analysis of te Velde et al [1].
The meta-analysis focused on several domains: NDT vs control; NDT vs activity based approaches; NDT vs Body Structure and Function; NDT vs environmental based; NDT low dose vs high dose, based on the findings from 34 studies, 16 of which were published before 2000. Subject groups were mixed and different subject groups were in the same comparison, dosage was not always equal, some studies focused on upper limb, some lower limb to name a few of the limitations. For example, the first study in the NDT vs activity-based approaches compared 112 hours of Constraint Induced Movement Therapy to 16 hours of NDT [1,4]. This meta-analysis hardly offers a current perspective on the state of Bobath and NDT practice and much of the discussion is based on misinterpretation of Bobath clinical practice. There is no one way to manage a child with CP- there are over 100 interventions- and Bobath clinical practice contains many of those listed in the SRs published by Novak et al [5].
The recommendation to deimplement Bobath and NDT appears to be short sighted. It would result in the loss of some excellent instructive courses about clinical reasoning for clinical management of infants, children and young people with CP. It would result in the loss of clinical expertise of Bobath trained clinicians who offer in-depth knowledge and the clinical reasoning and activity-based treatment skills to improve the lived experience of people with CP. Maybe a better conclusion would be to accept the results of the study very cautiously, recognizing the limitations of the methodology and the complexity of the clinical management of cerebral palsy, which requires an individual approach based on sound in-depth clinical reasoning. Future studies would be better to implement cohorts of children at comparable age, GMFCS levels and diagnosis receiving equal intervention dosage, and focus on the ingredients of current Bobath clinical practice.
References:
1. te Velde A, Morgan C, Finch-Edmondson M, et al. Neurodevelopmental Therapy for Cerebral Palsy: A Meta-analysis. Pediatrics. 2022;149(6):e2021055061. 2. Kolaski K, Romeiser Logan L, Goss KD, et al. Quality appraisal of systematic reviews of interventions for children with cerebral palsy reveals critically low confidence. Dev Med Child Neurol 2021; 63(11):1316-1326. 2. Mayston M. Bobath and NeuroDevelopmental Therapy: what is the future? Dev Med Child Neurol 2016; 58 (10):994. 4.Al-Oraibi S, Eliasson A-C. Implementation of constraint-induced movement therapy for young children with unilateral cerebral palsy in Jordan: a home-based model. Disabil Rehabil 2011;33(21–22):2006–2012. 5. Mayston M, Rosenbloom L. Please proceed with caution. Dev Med Child Neurol 2014; (56)4: 385-396.